Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

102.78
+1.231.21%
Post-market: 102.780.00000.00%19:44 EDT
Volume:995.23K
Turnover:102.71M
Market Cap:6.24B
PE:11.88
High:104.53
Open:101.37
Low:100.54
Close:101.55
Loading ...

Chimerix Inc - Transaction Valued at $8.55 per Share

THOMSON REUTERS
·
05 Mar

Chimerix Inc - Transaction Valued at $935 Million, or $8.55 per Share

THOMSON REUTERS
·
05 Mar

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

PR Newswire
·
05 Mar

Novartis Earns Near-Best Overall Rating As Profit Growth Climbs

Blockhead
·
05 Mar

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest

Zacks
·
05 Mar

Top Research Reports for Novo Nordisk, Coca-Cola & Wells Fargo

Zacks
·
05 Mar

Ensign Group Expands Healthcare Portfolio With Key Acquisitions

Zacks
·
05 Mar

3 Small-Cap Stocks Skating on Thin Ice

StockStory
·
04 Mar

5 Stocks With Recent Price Strength Defying a Weak February

Zacks
·
04 Mar

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey
·
04 Mar

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?

Zacks
·
04 Mar

4 Stocks Trading Near 52-Week High With More Upside Potential

Zacks
·
03 Mar

New Strong Buy Stocks for March 3rd

Zacks
·
03 Mar

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

Zacks
·
28 Feb

International Markets and Jazz (JAZZ): A Deep Dive for Investors

Zacks
·
28 Feb

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
28 Feb

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
27 Feb

Wells Fargo Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Faces DEI Challenges Amidst Executive Order and Growing Scrutiny

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
27 Feb